Form 8-K - Current report:
SEC Accession No. 0001683168-23-001027
Filing Date
2023-02-17
Accepted
2023-02-17 16:01:21
Documents
15
Period of Report
2023-02-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acon_8k.htm   iXBRL 8-K 35226
2 CERTIFICATE OF DESIGNATION OF SERIES A PREFERRED STOCK DATED FEBRUARY 16, 2023 aclarion_ex0301.htm EX-3.1 16604
3 SECURITIES PURCHASE AGREEMENT DATED FEBRUARY 16, 2023 BETWEEN ACLARION, INC. AND aclarion_ex1001.htm EX-10.1 47053
  Complete submission text file 0001683168-23-001027.txt   337761

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE acon-20230216.xsd EX-101.SCH 3993
5 XBRL DEFINITION FILE acon-20230216_def.xml EX-101.DEF 26648
6 XBRL LABEL FILE acon-20230216_lab.xml EX-101.LAB 36765
7 XBRL PRESENTATION FILE acon-20230216_pre.xml EX-101.PRE 25272
9 EXTRACTED XBRL INSTANCE DOCUMENT acon_8k_htm.xml XML 5667
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

EIN.: 473324725 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41358 | Film No.: 23642381
SIC: 8071 Services-Medical Laboratories